seed
Stage
1
Investors
About
ProFactor Pharma Ltd (PFP) is a UK biotech company developing low-cost recombinant factor VIII (FVIII) treatments to improve availability for people with Haemophilia A, addressing a large undertreated patient population.
Explore ProFactor Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.